PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2017 Edition

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2995

Where’s your place in the CMO hierarchy?
Find out in the CMO industry’s authoritative analysis of manufacturing of NDA approvals. This CMO scorecard was compiled through hundreds of professional hours of research and analysis, and is presented in a 40-page report with over 30 graphs and tables. Only CMO Scorecard enables the CMO industry to benchmark its performance over time, and CMOs to benchmark their performance against the industry.

Our research team crunched the numbers on 2016 drug approvals authorized by FDA’s CDER, CBER, Fast Track and Breakthrough drugs, and selected EMA approved drugs. For the first time, we are including information on the location of outsourced dose manufacturing facilities.

PharmSource’s data-rich Trend Report, CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2017 Edition, concludes that 2016 was not a halcyon year for new drug approvals with only 25 NMEs approved since 2010.

Scope

NA

Reasons to Buy

This report is required reading for:

CMO executives and strategic decision-makers who seriously follow the global CMO industry, including dose and API manufacturers.

Bio/Pharma sponsors that buy contract manufacturing services and need to understand contract manufacturing industry drivers.

Table of Contents

1 Executive Summary

3 Introduction

4 NDA Approvals Overview

6 US vs. EU Approval Performance

7 Outsourced Dose Manufacture

12 Special Product Categories

17 Outsourcing by Global Bio/Pharma

Companies

18 Outsourced Dose Form

Manufacture by Country

21 CMO Performance

27 Outsourced API Approvals

29 What It Means

31 Note on Methodology

32 Appendix A

33 Appendix B

36 Appendix C

40 Appendix D

42 Appendix E

Table

Table 1 Approvals by Dosage Form

Table 2 Outsourced NDA Approvals by Dosage Form

Table 3 Outsourcing by Sponsor Type and FDA Approval Type 2011-2016

Table 4 Dose CMOs Receiving Approvals in 2016

Table 5 API CMOs Receiving NME Approvals in 2016

Figures

Figure 1 NDA Approvals 2007-2016

Figure 2 NDA Approvals by Sponsor Type 2007-2016

Figure 3 EMA Approvals 2012-2016

Figure 4 Share of NDA Approvals Outsourced 2007-2016

Figure 5 Absolute Numbers of Outsourced NDA Approvals 2007-2016

Figure 6 Outsourcing of Small and Large Molecule API NMEs 2007-2016

Figure 7 Outsourcing of NME Approvals by Sponsor Type

Figure 8 Outsourcing of Non-NME NDA Approvals by Sponsor Type

Figure 9 Outsourcing of Orphan NMEs 2007-2016

Figure 10 Breakthrough NME Drug Approvals 2013-2016

Figure 11 Fast Track NME Drug Approvals 2001-2016

Figure 12 NMEs Requiring Special Handling 2007-2016

Figure 13 Approval and Outsourcing of Advanced Formulation Technologies 2011-2016

Figure 14 Global Bio/pharma Outsourcing Propensity 2007-2016

Figure 15 Manufacturing Location for Outsourced Non-NME NDA Dose Manufacturing 2007-16

Figure 16 Manufacturing Location for Outsourced NME Dose Manufacturing 2007-2016

Figure 17 Manufacturing Location for In-House NME Dose Manufacturing 2007-2016

Figure 18 Manufacturing Location for In-House Non-NME NDA Dose Manufacturing 2007-2016

Figure 19 CMO Market Share of Parenteral NME Approvals 2007-2016

Figure 20 CMO Market Share of Parenteral Non-NME NDA Approvals 2007-2016

Figure 21 CMO Market Share of Solid NME Approvals 2007-2016

Figure 22 CMO Market Share of Solid, Non-NME Approvals 2007-2016

Figure 23 Outsourced NME API Manufacture 2007-2016

Frequently asked questions

PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2017 Edition thematic reports
Currency USD
$2,995

Can be used by individual purchaser only

$8,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2017 Edition in real time.

  • Access a live PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2017 Edition dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.